Breast Cancer

Latest News

FDA approval | Image Credit: BHM - stock.adobe.com

FDA Approves Datopotamab Deruxtecan for HR-Positive/HER2-Negative Metastatic Breast Cancer

By Pearl Steinzor

January 17th 2025

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

Marie-France Jilderda, MD, PhD Candidate Surgical Oncology at Leiden University Medical Center in the Netherlands.

BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer

By Cameron Santoro

January 15th 2025

Identifying Patients With Low-Risk Breast Cancer for De-escalated Therapy

By Cameron Santoro

January 13th 2025

Elinzanetant | Image credit: Basstock - stock.adobe.com

Elinzanetant Excels in Phase 3 Study for Vasomotor Symptom Relief

By Pearl Steinzor

January 9th 2025

Breast cancer research. | Image Credit: Chinnapong - stock.adobe.com

Impact of Sexual Counseling on Women With Breast Cancer

By Pearl Steinzor

January 8th 2025

Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

Experts discuss the impact of CDK4/G inhibitor use, including medication cost, total care costs, toxicity profiles, and strategies to manage and optimize patient outcomes in high-risk early breast cancer.

Visit Now

Watch the latest AJMC Peer Exchange on Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

More News

August 11th 2020

Are There Benefits to Awake Breast Cancer Surgery During COVID-19?

Maggie L. Shaw

In Italy, a study looked at reallocating resources meant for patients with breast cancer to those stricken with coronavirus disease 2019, finding that the former could benefit from fast-track awake surgery to reduce risk of cross-infection.

August 7th 2020

Survival Consistent for Women With Early-Stage Breast Cancer Despite Surgery Delays

Maggie L. Shaw

Delays in surgery to treat early-stage breast cancer and receiving neoadjuvant endocrine therapy did not decrease survival odds among female patients, authors report in the Journal of the American College of Surgeons.

August 3rd 2020

Global Incidence of Premenopausal, Postmenopausal Breast Cancer Rising

Maggie L. Shaw

Higher-income countries are seeing their rates of premenopausal breast cancer increase faster, whereas cases of postmenopausal breast cancer are increasing in number faster in lower-income studies.

July 30th 2020

Mortality Among Men With Breast Cancer Decreases With Adjuvant Chemotherapy

Maggie L. Shaw

Less than 1% of all breast cancers occur in men, making this a rare disease among that patient population, and most treatment guidelines are based on outcomes and survival rates seen in women with the disease.

July 28th 2020

Women With Extremely Dense Breast Tissue May Not Benefit From 3-D Mammography

Maggie L. Shaw

Compared with digital mammography, digital breast tomosynthesis, also called 3-dimensional (3-D) mammography, has been proven superior at effectively detecting breast cancer and leading to fewer recall visits, but more information is needed for how subgroups of women with different breast densities benefit from the screening method, especially those classified as having extremely dense breast tissue.

July 23rd 2020

Germline BRCA-Mutated Breast Cancer Does Not Increase Risk of Adverse Pregnancy Outcomes

Maggie L. Shaw

Women with early-onset germline BRCA-mutated breast cancer can have subsequent pregnancies without increasing their risk for disease recurrence, according to the authors of a recent study in Journal of Clinical Oncology.

July 21st 2020

Diagnostic Delays From COVID-19 May Increase Cancer-Related Deaths, UK Studies Say

Maggie L. Shaw

The next several years could bear witness to thousands of additional deaths from cancer that could have been prevented through routine diagnostic care that was delayed because of the coronavirus disease 2019 (COVID-19) pandemic, according to a pair of studies in The Lancet Oncology.

July 17th 2020

Male Breast Cancer Survival Similar to That in Women Despite Treatment Variation

Maggie L. Shaw

Because male breast cancer is such a rare disease, few strides have been made that convey advantages in its detection, incidence, and mortality. Most treatment guidelines have been extracted from studies performed among female patients.

July 14th 2020

Interval Breast Cancer Found Within 1 Year Linked to Worse Mortality

Maggie L. Shaw

Breast cancer diagnosed in the year following a negative result after a mammogram has now been associated with an increase in mortality compared with breast cancer detected at a screening, report JAMA Network Open study results.

July 9th 2020

Smoking History May Influence Adverse Outcomes Following Radiotherapy for Breast Cancer

Maggie L. Shaw

Smoking history can both increase the risk of cancer and create a hypoxic environment within the body, leading to poor outcomes, including less-effective treatment, among patients who undergo radiotherapy.

July 7th 2020

Can Early Screening Reduce Breast Cancer Mortality Among Childhood Cancer Survivors?

Gianna Melillo

In survivors of childhood cancer, early initiation of annual breast cancer screening with MRI, with or without mammography, may reduce breast cancer mortality by half or more, according to a study published in Annals of Internal Medicine.

July 1st 2020

Study Results Show Possible Link Between Medicaid Expansion, Drop in Advanced Breast Cancer

Maggie L. Shaw

Despite ongoing disparities in the use of health care services among races/ethnicities and ages, as well as by insurance status, African American women with advanced breast cancer benefited the most following implementation of the Affordable Care Act in states that chose to expand Medicaid coverage.

July 1st 2020

Closing Thoughts on Metastatic Breast Cancers

July 1st 2020

Assessing the Value of Personalized Treatment in mBC

July 1st 2020

Considerations for NGS Testing in mTNBC

July 1st 2020

Treatment Options in Metastatic TNBC

July 1st 2020

Role of PARP Inhibition and I/O Therapy in TNBC

July 1st 2020

IMpassion130 Trial Data on PD-L1+ Tumors in TNBC

July 1st 2020

Sequencing of Therapy in R/R HER2+ mBC

July 1st 2020

SOPHIA Trial in R/R HER2+ mBC

July 1st 2020

HER2CLIMB and NALA Trials: R/R HER2+ mBC

July 1st 2020

Evolving Treatment Landscape of R/R HER2+ mBC

July 1st 2020

Payer Coverage of IV Versus Oral Therapy in mBC

July 1st 2020

Compliance and Adherence to Therapy in mBC

July 1st 2020

Advantages of Oral Taxanes in mBC

July 1st 2020

Payer Coverage on Repeat Biopsy in mBC

July 1st 2020

Payer Perspective of Coverage on Cancer Therapies

July 1st 2020

SOLAR-1 Trial in Metastatic Breast Cancer

July 1st 2020

Treatment After Progression on CDK 4/6i in mBC

June 30th 2020

Novel Subcutaneous, At-Home Breast Cancer Treatment Approved

Maggie L. Shaw

The FDA approved Phesgo (pertuzumab/trastuzumab/hyaluronidase-zzxf) as a subcutaneous (SC) treatment for adult patients with metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer or early-stage HER-2 positive disease. The treatment combines 2 monoclonal antibodies in a single SC injection.

...

5 6 7 8 9 10 11 12 >